Showing results (161-170 of 191) with videos related to
Sort By:
Pageof 20
CNS Drugs|May 29, 2025
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational StudyGiovanni Novi, Francesca Bovis, Chiara Sciolla, et al.Multiple Sclerosis and Related Disorders|June 8, 2022
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple SclerosisMarta Ponzano, Irene Schiavetti, Francesca Bovis, et al.Annals of Clinical and Translational Neurology|June 24, 2021
Nusinersen in pediatric and adult patients with type III spinal muscular atrophyMaria Carmela Pera, Giorgia Coratti, Francesca Bovis, et al.JAMA Network Open|May 20, 2026
Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis ActivityRené Carvajal, Marta Ponzano, Carmen Tur, et al.The Journal of Infection|August 20, 2022
Intrapartum use of zidovudine in a large cohort of pregnant women living with HIV in ItalyLucia Taramasso, Francesca Bovis, Antonio Di Biagio, et al.European Journal of Neurology|April 24, 2024
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international studyGiorgia Coratti, Francesca Bovis, Maria Carmela Pera, et al.Muscle & Nerve|July 30, 2021
Different trajectories in upper limb and gross motor function in spinal muscular atrophyGiorgia Coratti, Maria Carmela Pera, Jacqueline Montes, et al.European Journal of Neurology|June 27, 2025
Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With NusinersenGiorgia Coratti, Francesca Bovis, Marika Pane, et al.Neuromuscular Disorders : NMD|January 4, 2022
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changesGiorgia Coratti, Maria Carmela Pera, Jacqueline Montes, et al.Arthritis & Rheumatology (Hoboken, N.J.)|August 1, 2014
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patientsFrancesca Minoia, Sergio Davì, AnnaCarin Horne, et al.Pageof 20